Enanta Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ENTA for the last quarter is 17.05 M USD, and it's 5.27% lower compared to the previous quarter. The net income of Q2 24 is -31.16 M USD.